Pompe disease: Shared and unshared features of lysosomal storage disorders

References

• Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 2012; 199:723-34; PMID:23185029; http://dx.doi.org/10.1083/jcb.201208152
   PubMed Web of Science ®Google Scholar
• Hirschhorn R, Reuser AJ. Glycogen Storage Disease Type II: Acid alpha-Glucosidase (Acid Maltase) Deficiency. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill, 2001:3389-420
   Google Scholar
• Lim JA, Li L, Raben N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci 2014; 6:177; PMID:25183957; http://dx.doi.org/10.3389/fnagi.2014.00177
   PubMed Web of Science ®Google Scholar
• Zhu Y, Jiang JL, Gumlaw NK, Zhang J, Bercury SD, Ziegler RJ, Lee K, Kudo M, Canfield WM, Edmunds T, et al. Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease. Mol Ther 2009; 17:954-63; PMID:19277015; http://dx.doi.org/10.1038/mt.2009.37
   PubMed Web of Science ®Google Scholar
• Maga JA, Zhou J, Kambampati R, Peng S, Wang X, Bohnsack RN, Thomm A, Golata S, Tom P, Dahms NM, et al. Glycosylation-independent lysosomal targeting of acid alpha-glucosidase enhances muscle glycogen clearance in Pompe mice. J Biol Chem 2013; 288:1428-38; PMID:23188827; http://dx.doi.org/10.1074/jbc.M112.438663
   PubMed Web of Science ®Google Scholar
• Koeberl DD, Austin S, Case LE, Smith EC, Buckley AF, Young SP, Bali D, Kishnani PS. Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. FASEB J 2014; 28:2171-6; PMID:24443373; http://dx.doi.org/10.1096/fj.13-241893
   PubMed Web of Science ®Google Scholar
• Porto C, Ferrara MC, Meli M, Acampora E, Avolio V, Rosa M, Cobucci-Ponzano B, Colombo G, Moracci M, Andria G, et al. Pharmacological Enhancement of alpha-Glucosidase by the Allosteric Chaperone N-acetylcysteine. Mol Ther 2012; 20:2201-11; PMID:22990675; http://dx.doi.org/10.1038/mt.2012.152
   PubMed Web of Science ®Google Scholar
• Byrne BJ, Falk DJ, Pacak CA, Nayak S, Herzog RW, Elder ME, Collins SW, Conlon TJ, Clement N, Cleaver BD, et al. Pompe disease gene therapy. Hum Mol Genet 2011; 20:R61-8; PMID:21518733; http://dx.doi.org/10.1093/hmg/ddr174
   PubMed Web of Science ®Google Scholar
• Smith BK, Collins SW, Conlon TJ, Mah CS, Lawson LA, Martin AD, Fuller DD, Cleaver BD, Clément N, Phillips D, et al. Phase III trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. Hum Gene Ther 2013; 24:630-40; PMID:23570273; http://dx.doi.org/10.1089/hum.2012.250
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22:124-31; PMID:20034776; http://dx.doi.org/10.1016/j.ceb.2009.11.014
   PubMed Web of Science ®Google Scholar
• Raben N, Takikita S, Pittis MG, Bembi B, Marie SKN, Roberts A, Page L, Kishnani PS, Schoser BG, Chien YH, et al. Deconstructing Pompe disease by analyzing single muscle fibers. Autophagy 2007; 3:546-52; PMID:17592248; http://dx.doi.org/10.4161/auto.4591
   PubMed Web of Science ®Google Scholar
• Hung YH, Chen LM, Yang JY, Yang WY. Spatiotemporally controlled induction of autophagy-mediated lysosome turnover. Nat Commun 2013; 4:2111; PMID:23817530; http://dx.doi.org/10.1038/ncomms3111
   PubMed Web of Science ®Google Scholar
• Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, Yamamoto A, Hamasaki M, Noda T, Isaka Y, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. Embo J 2013; 32:2336-47; PMID:23921551; http://dx.doi.org/10.1038/emboj.2013.171
   PubMed Web of Science ®Google Scholar
• Sardiello M, Ballabio A. Lysosomal enhancement: a CLEAR answer to cellular degradative needs. Cell Cycle 2009; 8:4021-2; PMID:19949301; http://dx.doi.org/10.4161/cc.8.24.10263
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Li L, Lim J-A, Patange S, Raben N, Puertollano R. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 2014; 7:ra9; PMID:24448649; http://dx.doi.org/10.1126/scisignal.2004754
   PubMed Web of Science ®Google Scholar
• Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, Puri C, Pignata A, Martina JA, Sardiello M, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 2011; 21:421-30; PMID:21889421; http://dx.doi.org/10.1016/j.devcel.2011.07.016
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 2012; 8:903-14; PMID:22576015; http://dx.doi.org/10.4161/auto.19653
   PubMed Web of Science ®Google Scholar
• Martina JA, Puertollano R. RRAG GTPases link nutrient availability to gene expression, autophagy and lysosomal biogenesis. Autophagy 2013; 9:928-30; PMID:23524842; http://dx.doi.org/10.4161/auto.24371
   PubMed Web of Science ®Google Scholar
• Settembre C, Ballabio A. Lysosomal adaptation: how the lysosome responds to external cues. Cold Spring Harbor Perspect Biol 2014; 1-17
   Web of Science ®Google Scholar
• Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 2015; 17:288-99; PMID:25720963; http://dx.doi.org/10.1038/ncb3114
   PubMed Web of Science ®Google Scholar
• Moskot M, Montefusco S, Jakobkiewicz-Banecka J, Mozolewski P, Wegrzyn A, Di Bernardo D, Węgrzyn G, Medina DL, Ballabio A, Gabig-Cimińska M. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J Biol Chem 2014; 289:17054-69; PMID:24770416; http://dx.doi.org/10.1074/jbc.M114.555300
   PubMed Web of Science ®Google Scholar
• Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K, Ory DS, Vanier MT, Walkley SU. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 2009; 4:e6951; PMID:19750228; http://dx.doi.org/10.1371/journal.pone.0006951
   PubMed Web of Science ®Google Scholar
• Song W, Wang F, Lotfi P, Sardiello M, Segatori L. 2-Hydroxypropyl-beta-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J Biol Chem 2014; 289:10211-22; PMID:24558044; http://dx.doi.org/10.1074/jbc.M113.506246
   PubMed Web of Science ®Google Scholar
• Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med 2013; 5:691-706; PMID:23606558; http://dx.doi.org/10.1002/emmm.201202176
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Li H, Puertollano R. Novel roles for the MiTFTFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell Mol Life Sci 2014; 71:2483-97; PMID:24477476; http://dx.doi.org/10.1007/s00018-014-1565-8
   PubMed Web of Science ®Google Scholar
• Feeney EJ, Spampanato C, Puertollano R, Ballabio A, Parenti G, Raben N. What else is in store for autophagy? Exocytosis of autolysosomes as a mechanism of TFEB-mediated cellular clearance in Pompe disease. Autophagy 2013; 9:1117-8; PMID:23669057; http://dx.doi.org/10.4161/auto.24920
   PubMed Web of Science ®Google Scholar
• DeRuisseau LR, Fuller DD, Qiu K, DeRuisseau KC, Donnelly WH, Jr., Mah C, Reier PJ, Byrne BJ. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 2009; 106:9419-24; PMID:19474295; http://dx.doi.org/10.1073/pnas.0902534106
   PubMed Web of Science ®Google Scholar
• Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, Byrne BJ. The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol 2013; 189:241-9; PMID:23797185; http://dx.doi.org/10.1016/j.resp.2013.06.007
   PubMed Web of Science ®Google Scholar
• Falk DJ, Todd AG, Lee S, Soustek MS, ElMallah MK, Fuller DD, Notterpek L, Byrne BJ. Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet 2015; 24:625-36; PMID:25217571; http://dx.doi.org/10.1093/hmg/ddu476
   PubMed Web of Science ®Google Scholar
• Todd AG, McElroy JA, Grange RW, Fuller DD, Walter GA, Byrne BJ, Falk DJ. Correcting neuromuscular deficits with gene therapy in Pompe disease. Ann Neurol 2015; PMID:25925726; http://dx.doi.org/10.1002/ana.24433
   PubMed Web of Science ®Google Scholar
• Osellame LD, Duchen MR. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration. Br J Pharmacol 2014; 171:1958-72; PMID:24116849; http://dx.doi.org/10.1111/bph.12453
   PubMed Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12:9-14; PMID:21179058; http://dx.doi.org/10.1038/nrm3028
   PubMed Web of Science ®Google Scholar
• Martins C, Hulkova H, Dridi L, Dormoy-Raclet V, Grigoryeva L, Choi Y, Langford-Smith A, Wilkinson FL, Ohmi K, DiCristo G, et al. Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model. Brain 2015; 138:336-55; PMID:25567323; http://dx.doi.org/10.1093/brain/awu355
   PubMed Web of Science ®Google Scholar
• de Pablo-Latorre R, Saide A, Polishhuck EV, Nusco E, Fraldi A, Ballabio A. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 2012; 21:1770-81; PMID:22215441; http://dx.doi.org/10.1093/hmg/ddr610
   PubMed Web of Science ®Google Scholar
• Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, Waddington SN, Schapira AH, Duchen MR. Mitochondria and quality control defects in a mouse model of Gaucher disease–links to Parkinson's disease. Cell Metab 2013; 17:941-53; PMID:23707074; http://dx.doi.org/10.1016/j.cmet.2013.04.014
   PubMed Web of Science ®Google Scholar
• Cox TM, Cachon-Gonzalez MB. The cellular pathology of lysosomal diseases. J Pathol 2012; 226:241-54; PMID:21990005; http://dx.doi.org/10.1002/path.3021
   PubMed Web of Science ®Google Scholar
• Parrington J, Tunn R. Ca(2+) signals, NAADP and two-pore channels: role in cellular differentiation. Acta Physiologica 2014; 211:285-96; PMID:24702694; http://dx.doi.org/10.1111/apha.12298
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E, Platt FM. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 2011; 50:200-5; PMID:21724254; http://dx.doi.org/10.1016/j.ceca.2011.03.010
   PubMed Web of Science ®Google Scholar
• Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol Dis 2014; 67:9-17; PMID:24631719; http://dx.doi.org/10.1016/j.nbd.2014.03.001
   PubMed Web of Science ®Google Scholar
• Ishigaki K, Mitsuhashi S, Kuwatsuru R, Murakami T, Shishikura K, Suzuki H, Hirayama Y, Nonaka I, Osawa M. High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation. Acta Neuropathol 2010; 120:537-43; PMID:20680637; http://dx.doi.org/10.1007/s00401-010-0732-8
   PubMed Web of Science ®Google Scholar
• Jennings JJ Jr., Zhu JH, Rbaibi Y, Luo X, Chu CT, Kiselyov K. Mitochondrial aberrations in mucolipidosis Type IV. J Biol Chem 2006; 281:39041-50; PMID:17056595; http://dx.doi.org/10.1074/jbc.M607982200
   PubMed Web of Science ®Google Scholar
• Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J, Forte M, d'Azzo A. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis. Mol Cell 2009; 36:500-11; PMID:19917257; http://dx.doi.org/10.1016/j.molcel.2009.10.021
   PubMed Web of Science ®Google Scholar
• Luiro K, Kopra O, Blom T, Gentile M, Mitchison HM, Hovatta I, Törnquist K, Jalanko A. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. J Neurosci Res 2006; 84:1124-38; PMID:16941499; http://dx.doi.org/10.1002/jnr.21015
   PubMed Web of Science ®Google Scholar
• Warnock A, Tan L, Li C, An Haack K, Narayan SB, Bennett MJ. Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease). Biochem Biophys Res Commun 2013; 436:645-9; PMID:23769828; http://dx.doi.org/10.1016/j.bbrc.2013.04.113
   PubMed Web of Science ®Google Scholar
• Wang F, Segatori L. Remodeling the proteostasis network to rescue glucocerebrosidase variants by inhibiting ER-associated degradation and enhancing ER folding. PLoS One 2013; 8:e61418; PMID:23620750; http://dx.doi.org/10.1371/journal.pone.0061418
   PubMed Web of Science ®Google Scholar
• Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol 2014; 24:400-6; PMID:24698685; http://dx.doi.org/10.1016/j.tcb.2014.03.003
   PubMed Web of Science ®Google Scholar
• Efeyan A, Zoncu R, Chang S, Gumper I, Snitkin H, Wolfson RL, Kirak O, Sabatini DD, Sabatini DM. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 2013; 493:679-83; PMID:23263183; http://dx.doi.org/10.1038/nature11745
   PubMed Web of Science ®Google Scholar
• Shemesh A, Wang Y, Yang Y, Yang GS, Johnson DE, Backer JM, Pessin JE, Zong H. Suppression of mTOR1 activation in acid- alpha -glucosidase deficient cells and mice is ameliorated by leucine supplementation. Am J Physiol Regul Integr Comp Physiol 2014; 307:R1251-9; PMID:25231351; http://dx.doi.org/10.1152/ajpregu.00212.2014
   PubMed Web of Science ®Google Scholar
• Rong Y, McPhee CK, Deng S, Huang L, Chen L, Liu M, Tracy K, Baehrecke EH, Yu L, Lenardo MJ. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc Natl Acad Sci U S A 2011; 108:7826-31; PMID:21518918; http://dx.doi.org/10.1073/pnas.1013800108
   PubMed Web of Science ®Google Scholar
• Herrera JL SE, Gomez JF, Alonso R. Energy status in skeletal muscle in a mouse model of Pompe disease. J Neuromusc Giseases 2015; 1:S43
   Google Scholar
• Negroni JA, Morotti S, Lascano EC, Gomes AV, Grandi E, Puglisi JL, Bers DM. Beta-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model. J Mol Cell Cardiol 2015; 81:162-75; PMID:25724724; http://dx.doi.org/10.1016/j.yjmcc.2015.02.014
   PubMed Web of Science ®Google Scholar